NeuroConnect: Home-Based tDCS Neurotherapy for Autism

Overview

We employ tDCS, a non-invasive neuromodulation technique shown in research to enhance neuroplasticity and cognitive function. Our proprietary algorithms optimise stimulation parameters for ASD. The system enables clinicians to conduct real-time progress tracking and remote monitoring, offering flexibility for end users. Additionally, our solution by combining tDCS with gamified cognitive training makes the treatment both engaging and motivating for users.

  • NeuroConnect: Home-Based tDCS Neurotherapy for Autism 0
  • NeuroConnect: Home-Based tDCS Neurotherapy for Autism 1
  • NeuroConnect: Home-Based tDCS Neurotherapy for Autism 2
Technical name of innovation
NeuroConnect: Home-Based tDCS Neurotherapy for Autism
Commercialisation opportunities
Collaboration for product development Product distributionInvestment in startup
Problem addressed

Current clinical neurotherapy for Autism Spectrum Disorder faces severe barriers. This includes (1) expensive treatment costs and rigid logistical demands that limit family access; (2) low patient adherence due to unengaging traditional therapies; and (3) a lack of remote monitoring tools for clinicians. These challenges make consistent, effective cognitive rehabilitation highly inaccessible for end users.

Innovation
  • The first home-based neurotherapy system for ASD integrating a wireless tDCS headset, a gamified cognitive training app, and a remote clinician portal.
  • Connects hardware telemetry directly to a clinician portal for real-time, remote protocol optimisation.
  • Hardware features engineered specifically to make tDCS safe for home use.
Key impact
  • Provides evidence-based neurotherapy to individuals with ASD.
  • Turns cognitive ASD-specific training into an easy home-based daily routine.
  • Our solution removes the barrier of costly clinic visits, making tDCS truly accessible, affordable, and scalable applications.
Award
  • Supported Start-up in the Angel Fund (TSSSU-O) 2026-27
  • Top Performer in Micro Fund 2025/26 Cohort 2
Application
  • Provides safe, daily home-based neuromodulation and cognitive training for ASD families
  • Delivers real-time efficacy assessment and quantifiable outcome measurements for cognitive training
  • Conducts reliable progress monitoring for behavioral and cognitive function improvements

Patent

  • US 63/858,516
  • CN 202511576907.7 
  • TW 114145111
The Hong Kong Polytechnic University (PolyU)

With over 80 years of proud tradition and ranking among the world’s top 100 institutions, The Hong Kong Polytechnic University (PolyU) aspires to be a leading university with world-class research and education.

PolyU is a home for educating thinkers, discoverers, innovators and communicators in delivering positive impact. We are committed to nurturing tomorrow’s leaders today, through a holistic education that provides graduates unrivaled placements to thrive in communities, industries and businesses.

Enquiry